![](https://webarchive.library.unt.edu/eot2008/20081012083646im_/http://www.nci.nih.gov/images/spacer.gif) |
¿Preguntas sobre el cáncer?
![](https://webarchive.library.unt.edu/eot2008/20081012083646im_/http://www.nci.nih.gov/images/spacer.gif)
|
1-800-422-6237
(1-800-4-CANCER)
|
![](https://webarchive.library.unt.edu/eot2008/20081012083646im_/http://www.nci.nih.gov/images/spacer.gif)
|
Llame de lunes a viernes de 9:00 a.m. a 4:30 p.m., hora local en Estados Unidos y sus territorios. |
|
![](https://webarchive.library.unt.edu/eot2008/20081012083646im_/http://www.nci.nih.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081012083646im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081012083646im_/http://www.nci.nih.gov/images/spacer.gif)
| Sustancia radiactiva que se estudia en la tomografía por emisión de positrones (TEP) para detectar el cáncer y vigilar la respuesta de algunos tipos de cáncer al tratamiento. El flúor F 18 FEQA se acopla al receptor del factor de crecimiento epidérmico (RFCE) que se encuentra en la superficie de algunas células tumorales. Es un tipo de radiofármaco. |
![](https://webarchive.library.unt.edu/eot2008/20081012083646im_/http://www.nci.nih.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081012083646im_/http://www.nci.nih.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081012083646im_/http://www.nci.nih.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081012083646im_/http://www.nci.nih.gov/images/spacer.gif) |